Table 3.

Immune recovery in peripheral blood after congenic purified hematopoietic stem cell transplantation



Total

Donor-type

Host-type

CD4+
CD8+
B220+
CD4+
CD8+
CD4+
CD8+
Before transplantation   773 ± 147   379 ± 69   2912 ± 714   —   —   —   —  
Day + 28        
400 KTLS   429 ± 98*  265 ± 79   77 ± 60  2 ± 1  1 ± 1  427 ± 98*  264 ± 78  
1000 KTLS   548 ± 100   292 ± 101   465 ± 267   10 ± 6   5 ± 3   538 ± 97   287 ± 99  
5000 KTLS   653 ± 213   316 ± 134   1481 ± 464   65 ± 71   23 ± 20   588 ± 176   292 ± 125  
Day + 35        
400 KTLS   633 ± 202  383 ± 122   438 ± 364  48 ± 31  13 ± 8  431 ± 98  278 ± 83  
1000 KTLS   866 ± 143   412 ± 135   1201 ± 482   152 ± 80   45 ± 26   714 ± 114   367 ± 112  
5000 KTLS   1028 ± 214   458 ± 137   2897 ± 540   366 ± 127   115 ± 38   662 ± 149   342 ± 135  
Day + 42        
400 KTLS   1130 ± 198  575 ± 135   1556 ± 1408  401 ± 150  113 ± 44  729 ± 185   462 ± 155  
1000 KTLS   1345 ± 211   628 ± 118   3056 ± 839   645 ± 151   208 ± 56   700 ± 123   420 ± 111  
5000 KTLS   1563 ± 349   700 ± 184   4651 ± 845   937 ± 263   320 ± 101   626 ± 102   379 ± 89  
Day + 56        
400 KTLS   1486 ± 640   724 ± 328   2571 ± 2575*  929 ± 464  304 ± 169  558 ± 219   420 ± 191  
1000 KTLS   1371 ± 282   641 ± 83   2543 ± 1317   857 ± 187   317 ± 71   514 ± 159   324 ± 57  
5000 KTLS   1816 ± 353   819 ± 158   4973 ± 1015   1387 ± 272   503 ± 103   429 ± 90   315 ± 97  
Day + 70        
400 KTLS   2109 ± 619*  983 ± 302  5721 ± 4035*  1561 ± 486  547 ± 185  548 ± 174   436 ± 153 
1000 KTLS   1597 ± 507   680 ± 154   4316 ± 2137   1189 ± 434   413 ± 139   408 ± 113   267 ± 28  
5000 KTLS
 
2476 ± 521
 
1111 ± 234
 
8148 ± 1873
 
2048 ± 441
 
802 ± 172
 
428 ± 84
 
309 ± 87
 


Total

Donor-type

Host-type

CD4+
CD8+
B220+
CD4+
CD8+
CD4+
CD8+
Before transplantation   773 ± 147   379 ± 69   2912 ± 714   —   —   —   —  
Day + 28        
400 KTLS   429 ± 98*  265 ± 79   77 ± 60  2 ± 1  1 ± 1  427 ± 98*  264 ± 78  
1000 KTLS   548 ± 100   292 ± 101   465 ± 267   10 ± 6   5 ± 3   538 ± 97   287 ± 99  
5000 KTLS   653 ± 213   316 ± 134   1481 ± 464   65 ± 71   23 ± 20   588 ± 176   292 ± 125  
Day + 35        
400 KTLS   633 ± 202  383 ± 122   438 ± 364  48 ± 31  13 ± 8  431 ± 98  278 ± 83  
1000 KTLS   866 ± 143   412 ± 135   1201 ± 482   152 ± 80   45 ± 26   714 ± 114   367 ± 112  
5000 KTLS   1028 ± 214   458 ± 137   2897 ± 540   366 ± 127   115 ± 38   662 ± 149   342 ± 135  
Day + 42        
400 KTLS   1130 ± 198  575 ± 135   1556 ± 1408  401 ± 150  113 ± 44  729 ± 185   462 ± 155  
1000 KTLS   1345 ± 211   628 ± 118   3056 ± 839   645 ± 151   208 ± 56   700 ± 123   420 ± 111  
5000 KTLS   1563 ± 349   700 ± 184   4651 ± 845   937 ± 263   320 ± 101   626 ± 102   379 ± 89  
Day + 56        
400 KTLS   1486 ± 640   724 ± 328   2571 ± 2575*  929 ± 464  304 ± 169  558 ± 219   420 ± 191  
1000 KTLS   1371 ± 282   641 ± 83   2543 ± 1317   857 ± 187   317 ± 71   514 ± 159   324 ± 57  
5000 KTLS   1816 ± 353   819 ± 158   4973 ± 1015   1387 ± 272   503 ± 103   429 ± 90   315 ± 97  
Day + 70        
400 KTLS   2109 ± 619*  983 ± 302  5721 ± 4035*  1561 ± 486  547 ± 185  548 ± 174   436 ± 153 
1000 KTLS   1597 ± 507   680 ± 154   4316 ± 2137   1189 ± 434   413 ± 139   408 ± 113   267 ± 28  
5000 KTLS
 
2476 ± 521
 
1111 ± 234
 
8148 ± 1873
 
2048 ± 441
 
802 ± 172
 
428 ± 84
 
309 ± 87
 

Lethally irradiated (10.5 Gy) CD45.2 mice received transplants of 3 different doses (400, 1000, and 5000) of KTLS cells that corresponded with T-cell-depleted bone marrow cell doses used in Table 2 (eg, 400 KTLS = 8 × 105 T-cell-depleted bone marrow cells) from the congenic CD45.1 mice. Peripheral blood was harvested at various time points after stem cell transplantation. The blood samples were then stained and analyzed by flow cytometry. The absolute counts were determined using Flow-Count fluorospheres. Data represent absolute count (mean ± SD/μL blood) in peripheral blood from 4 to 15 animals per group per time point. All B cells were donor origin (Figure 2). KTLS indicates c-Kit+Thy1.1lowLin−/lowSca-1+ hematopoietic stem cells; —, not done. CD45.2 mice indicates C57BL/6, CD45.2, Thy1.2 mice. CD45.1 mice indicates C57BL/Ka, CD45.1, Thy1.1 mice.

*

P < .05, in any one of the following comparisons: 400 KTLS versus 1000 KTLS, 400 KTLS versus 5000 KTLS, and 1000 KTLS versus 5000 KTLS.

P < .05, any 2 of the following comparisons: 400 KTLS versus 1000 KTLS, 400 KTLS versus 5000 KTLS, and 1000 KTLS versus 5000 KTLS.

P < .05, all of the following comparisons: 400 KTLS versus 1000 KTLS, 400 KTLS versus 5000 KTLS, and 1000 KTLS versus 5000 KTLS.

or Create an Account

Close Modal
Close Modal